Findings from the AltaValve Early Feasibility Study show that patients with a leaking mitral valve continue to receive clinical benefit up to one year after atrial fixation transcatheter mitral valve replacement (TMVR). The researchers presented the latest data at the Society for Cardiovascular Angiography and Interventions (SCAI) 2026 Scientific Sessions and the Canadian Association of Interventional Cardiology/Association Canadienne de Cardiology d’Intervention (CAIC-ACCI) summit in Montreal.
Please follow and like us:
